These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6983863)

  • 1. Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size.
    Levin RM; Azimi PH; Dunphy MG
    Antimicrob Agents Chemother; 1982 Nov; 22(5):923-5. PubMed ID: 6983863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
    Powell M; Williams JD
    J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)].
    Braveny I
    Infection; 1979; 7 Suppl 6():532-9. PubMed ID: 317812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro microbiological activity and stability of cefaclor.
    Gillett AP; Andrews JM; Wise R
    Postgrad Med J; 1979; 55 Suppl 4():9-11. PubMed ID: 44910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
    Sinai R; Hammerberg S; Marks MI; Pai CH
    Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Antimicrob Agents Chemother; 1992 Jan; 36(1):46-9. PubMed ID: 1590698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Doern GV; Chapin KC
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
    Anderson EL; Robinson PA; Tu KK; Adams CR
    South Med J; 1985 Jun; 78(6):643-6. PubMed ID: 3873708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM; Welch DF
    Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD; Powell M; Fah YS; Seymour A; Yuan M
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
    Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
    Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
    Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Haemophilus influenzae to chloramphenicol and eight beta-lactam antibiotics.
    Thirumoorthi MC; Kobos DM; Dajani AS
    Antimicrob Agents Chemother; 1981 Aug; 20(2):208-13. PubMed ID: 6974541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the inoculum effect with Haemophilus influenzae and beta-lactams.
    Balko T; Karlowsky JA; Palatnick LP; Zhanel GG; Hoban DJ
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):47-58. PubMed ID: 9990476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of Hemophilus influenzae type-b meningitis during cefaclor therapy for preseptal cellulitis.
    Brady MT; Barson WJ; Cannon HJ; Grossman LK
    Clin Pediatr (Phila); 1987 Mar; 26(3):132-4. PubMed ID: 3493104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of LY163892, cefaclor, and cefuroxime.
    Knapp CC; Washington JA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):131-3. PubMed ID: 3348605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.